Boston Neurosciences
2013
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$10M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of medical device company designed to non-invasively measure the absolute value of intracranial pressure (ICP), real-time cerebral blood flow autoregulation (CA) and intracranial volumetric wave monitoring. The company's ultrasound-based devices offers non-invasive ICP measurement for conditions such as traumatic brain injury, concussion, hydrocephalus, stroke, brain tumors, and other neurological diseases, enabling clinicians to obtain safer, faster, accurate and cost efficient measurements of absolute intracranial pressure values.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
- K. Barsausko 59 - B814
- Kaunas, LT-51423
- Lithuania
+370 (8-614) 00000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Boston Neurosciences’s full profile, request a free trial.
Boston Neurosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 16-Oct-2015 | $10M | 0000 | 0000 | Completed | Startup |
| 1. Grant | 0000 | Completed | Startup |
Boston Neurosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Boston Neurosciences Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 000000 00000000000 | Venture Capital-Backed | Pleasanton, CA | 000000&0 |
Boston Neurosciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Imprimatur Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Start Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Xeraya Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Boston Neurosciences Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Teo Dagi MD | Board Member & Chief Executive Officer | ||
| Remis Bistras Ph.D | President & Board Member | ||
| Edvardas Satkauskas | General Director |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Boston Neurosciences Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Aditya Puri | Xeraya Capital | Board Member | 000 0000 | |
| Aloyzas Petrikas | Self | Board Member | 000 0000 | |
| Christopher Hunt | Imprimatur Capital | Board Member | 000 0000 | |
| Edvardas Satkauskas | Boston Neurosciences | General Director | 000 0000 | |
| Remis Bistras Ph.D | Boston Neurosciences | President & Board Member | 000 0000 |